NCT07755163

Brief Summary

Purpose: This study was conducted to determine the effect of an online educational intervention on migrant women's knowledge and attitudes toward cancer screening. DesigN:This study was designed as a two-arm, parallel-group, randomized controlled trial with pre-test and post-test assessments. Method: The study population will consist of women registered at the Cancer Early Diagnosis, Screening and Training Center (KETEM) affiliated with the Erzincan Provincial Health Directorate. The sample size was calculated based on a two-group (intervention and control) and two-measurement (pre-test and post-test) study design. Using repeated-measures ANOVA with a medium effect size (d = 0.25), a significance level of 5% (α = 0.05), and a statistical power of 80% (1 - β = 0.80), the required sample size was determined to be 34 participants per group (34 in the intervention group and 34 in the control group), resulting in a minimum total sample of 68 participants. To account for potential attrition, it was planned to recruit 80 participants (approximately 20% more than the minimum required sample size).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started Aug 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Aug 2026Jan 2027

First Submitted

Initial submission to the registry

August 5, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

August 6, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 10, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2027

Last Updated

August 10, 2026

Status Verified

August 1, 2026

Enrollment Period

5 months

First QC Date

August 5, 2026

Last Update Submit

August 5, 2026

Conditions

Keywords

Migrant womenCancer screeningOnline educationKnowledge and attitudes

Outcome Measures

Primary Outcomes (2)

  • Cancer Screening Knowledge Scale

    The Cancer Screening Knowledge Scale is a 25-item questionnaire designed to assess participants' knowledge regarding cancer screening. Total scores range from 0 to 25, with higher scores indicating greater knowledge.

    From baseline to 5 weeks after baseline

  • Cancer Screening Attitude Scale-Short Form

    The Cancer Screening Attitude Scale-Short Form is a 15-item questionnaire used to assess participants' attitudes toward cancer screening. Total scores range from 15 to 75, with higher scores indicating more positive attitudes toward cancer screening.

    From baseline to 5 weeks after baseline

Study Arms (2)

SCREEN

EXPERIMENTAL
Other: Screening Cancer Readiness through Education and Empowerment for Newcomer Women

control group

ACTIVE COMPARATOR
Other: Control group

Interventions

Women assigned to the intervention group will be contacted by telephone using the contact information registered at the Cancer Early Diagnosis, Screening and Training Center (KETEM). For participants without a registered telephone number, home visits will be conducted using the addresses recorded in the KETEM database. Following completion of the baseline (pre-test) assessment, participants in the intervention group will receive an online cancer screening education program developed in accordance with the Turkish National Cancer Control Program of the General Directorate of Public Health, Ministry of Health of the Republic of Türkiye. The educational intervention will be delivered in three online sessions via WhatsApp video calls. During each session, participants will have the opportunity to ask questions, which will be answered by the researcher. Prior to each session, reminder text messages will be sent to participants' mobile phones to notify them of the date and time of the schede

SCREEN

Women assigned to the control group who are registered at the Cancer Early Diagnosis, Screening and Training Center (KETEM) will be contacted and invited to participate in the study. During the initial meeting, written informed consent will be obtained, after which the Personal Information Form and study questionnaires will be administered to collect baseline (pre-test) data. An appointment for the follow-up assessment will be scheduled approximately four weeks later. Five weeks after the baseline assessment, participants will be contacted by telephone to complete the post-test assessment. No educational intervention will be provided to the control group during the study period. After completion of the post-test assessment, participants in the control group will be offered the same cancer screening education program in accordance with the ethical principle of equity.

control group

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged 30-70 years. Able to read and write. Able to speak and understand Turkish. Have access to the internet at home or in the workplace. Own a smartphone or have access to a smartphone belonging to a family member that can be used by the participant.
  • Have no hearing, visual, cognitive, or orthopedic impairments that would prevent participation in the study.

You may not qualify if:

  • Diagnosis of a psychiatric disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Behavior

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Central Study Contacts

Ezgi Demirtürk Selçuk, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 5, 2026

First Posted

August 10, 2026

Study Start

August 6, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

January 25, 2027

Last Updated

August 10, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share